Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Bisoprolol
Drug ID BADD_D00277
Description Bisoprolol is a cardioselective β1-adrenergic blocking agent used to treat high blood pressure.[A180472,L7219] It is considered a potent drug with a long-half life that can be used once daily to reduce the need for multiple doses of antihypertensive drugs.[A180472] Bisoprolol is generally well tolerated, likely due to its β1-adrenergic receptor selectivity and is a useful alternative to non-selective β-blocker drugs in the treatment of hypertension such as [Carvedilol] and [Labetalol]. It may be used alone or in combination with other drugs to manage hypertension[L7219] and can be useful in patients with chronic obstructive pulmonary disease (COPD) due to its receptor selectivity.[A180562]
Indications and Usage For management of heart failure, angina pectoris, and mild to moderate hypertension and for secondary prevention of myocardial infarction (MI).
Marketing Status Prescription; Discontinued
ATC Code C07AB07
DrugBank ID DB00612
KEGG ID D02342
MeSH ID D017298
PubChem ID 2405
TTD Drug ID D0K3ZR
NDC Product Code Not Available
Synonyms Bisoprolol | Bisoprolol Fumarate (1:1) Salt, (+-)-Isomer | Bisoprolol Fumarate (2:1) Salt, (+-)-Isomer | Bisoprolol Hydrochloride | Hydrochloride, Bisoprolol | Bisoprolol Methanesulfonate Salt | Bisoprolol, (+-)-Isomer | Bisoprolol, Fumarate (1:1) Salt | Bisoprolol, Fumarate (2:1) Salt | CL-297939 | CL 297939 | CL297939 | Concor | EMD-33512 | EMD 33512 | EMD33512 | Bisoprolol Fumarate | Fumarate, Bisoprolol | Bisoprolol, (-)-Isomer
Chemical Information
Molecular Formula C18H31NO4
CAS Registry Number 66722-44-9
SMILES CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Adverse drug reactionCytochrome P450 2D6P10635T57392Not Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Sinus node dysfunction02.03.03.0170.006708%
Multiple organ dysfunction syndrome08.01.03.0570.001925%
Anaplastic large cell lymphoma T- and null-cell types16.17.02.002; 01.11.02.0020.001342%Not Available
Breast cancer in situ21.05.01.015; 16.10.01.0070.002683%Not Available
Congenital umbilical hernia07.16.03.003; 03.04.07.0060.003354%Not Available
Endocarditis enterococcal11.02.08.004; 02.09.03.0040.001342%Not Available
Faeces pale07.01.03.0050.001342%Not Available
Maternal drugs affecting foetus18.03.03.009; 12.03.03.0060.002683%Not Available
Neonatal respiratory distress syndrome22.11.02.010; 18.04.10.0030.002013%Not Available
Normal newborn18.08.06.0010.001342%Not Available
Small for dates baby18.04.02.0020.013417%Not Available
Trifascicular block02.03.01.0150.002683%Not Available
Live birth18.08.02.0070.001342%Not Available
Bradycardia neonatal18.04.07.004; 02.03.02.0190.004696%Not Available
Bifascicular block02.03.01.0200.002683%Not Available
Subacute cutaneous lupus erythematosus23.03.02.020; 10.04.03.012; 15.06.02.0120.002683%Not Available
Sopor17.02.04.021; 19.02.04.0020.006708%Not Available
Gastrointestinal ischaemia24.04.08.007; 07.15.02.0050.000350%Not Available
Lung hyperinflation22.02.04.0110.002013%Not Available
Cerebellar haematoma24.07.04.022; 17.08.01.0450.001050%Not Available
Foot deformity15.10.03.0050.001342%Not Available
Stress cardiomyopathy24.04.04.026; 02.04.01.0120.002013%Not Available
Quality of life decreased13.18.01.0130.001342%Not Available
Coma scale abnormal13.07.03.0120.001342%Not Available
Varicella virus test positive13.08.03.0330.001342%Not Available
Spinal pain17.10.01.020; 15.02.01.008; 08.01.08.0300.001342%Not Available
The 20th Page    First    Pre   20    Total 20 Pages